Skip to content

Short-term exercise intervention for stroke patients: a randomized controlled trial.

Clinical study of short-term exercise intervention in patients with ischemic stroke in subacute phase

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056043
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-31
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group:short-term exercise
Control group :No exercise intervention

Sponsors

Huashan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of "China Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018", including: (1) Acute onset; (2) Focal neurological deficit or comprehensive neurological deficit; (3) Imaging with responsible lesions or symptoms/signs lasting more than 24 hours; (4) Exclude non-vascular causes; (5) Brain CT/MRI to exclude cerebral hemorrhage. 2. Subacute stage of disease course (7 days to 6 months). 3. Aged 40-75 years, gender is not limited. 4. Vital signs are stable, able to complete routine post-stroke rehabilitation assessment and treatment. 5. Unilateral hemiplegia, lower limb Brunnstrom stage >= stage III, able to complete the CPET test and perform power cycling training. 6. Informed consent and voluntary participation in the researcher.

Exclusion criteria

Exclusion criteria: 1. Severe or uncontrollable high blood pressure, severe cardiac insufficiency, severe infection (pneumonia, etc.), diabetic ketosis, frequent epilepsy, and other diseases that clinicians believe may worsen by exercise; 2. There are uncontrolled clinical conditions (hyperthyroidism or hypothyroidism, severe liver and kidney damage, the acute activity of rheumatic diseases, electrolyte imbalance, severe anemia, etc.); 3. The patient has participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VO2peak;HRpeak;BPpeak;

Secondary

MeasureTime frame
Fugl-Meyer;Serum immunological indexes;MESSS;NIHSS;Berg balance scale;BDNF;SmO2;Cerebral blood flow;TMS-MEP;fMRI;DTI;MRS;

Countries

China

Contacts

Public ContactJie Jia

Huashan Hospital Fudan University

shannonjj@126.com+86 13611722357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026